C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men

By Laaksonen D.   Niskanen L.   Nyyssönen K.   Punnonen K.   Tuomainen T.-P.   Valkonen V.-P.   Salonen R.   Salonen J.  

Diabetologia, Vol. 47, Iss. 8, 2004-08 ,pp. : 1403-1410

Springer Publishing Company

Access to resources Recommend Favorite

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome

By Wang T.-D.   Chen W.-J.   Lin J.-W.   Chen M.-F.   Lee Y.-T.  

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 362-365

Elsevier

Access to resources Recommend Favorite

Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy

By Friedman A.N.   Hunsicker L.G.   Selhub J.   Bostom A.G.   The Collaborative Study Group  

Atherosclerosis, Vol. 172, Iss. 1, 2004-01 ,pp. : 121-125

Elsevier

Access to resources Recommend Favorite

Serum C-reactive protein and metabolic components

By Kawada Tomoyuki  

Endocrine, Vol. 44, Iss. 3, 2013-12 ,pp. : 819-819

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study

By Satar N.   Gaw A.   Scherbakova O.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite